Gynecology · Vaginal Leukoplakia

Treatment Options and Your Path Forward

At a Glance

Treatment for vaginal leukoplakia depends on the biopsy: mild vaginal cell changes may be monitored, while higher-grade changes often need tissue removal or CO2 laser after hidden invasion is assessed. Specialist care and long-term follow-up help detect recurrence.

Once your biopsy results have moved you past the descriptive label of leukoplakia, your care team will develop a treatment plan tailored to the specific cause. The goal of treatment is twofold: to remove or manage abnormal cells and to prevent the development of invasive cancer while preserving your quality of life ^[1].

Choosing a Treatment Based on Diagnosis

The path forward depends on the “grade” of the cells or the type of inflammation found during your biopsy.

Low-Grade Changes (VaIN 1 / vLSIL)

For VaIN 1, the most common “next step” is often no treatment at all. Because these mild changes frequently resolve on their own as the immune system clears the viral effect, doctors often recommend expectant management (close monitoring) ^[2]^[3]. You will likely return in 6 to 12 months for a repeat exam and HPV test ^[1].

High-Grade Changes (VaIN 2-3 / vHSIL)

Because high-grade lesions have a higher risk of progressing to cancer, active treatment is the standard recommendation ^[1].

Surgical Excision: This involves removing the patch of tissue. Excision is recommended if invasion cannot be excluded ^[4]. Excision ensures the pathologist has the entire lesion to check for invasive cells.
CO2 Laser Ablation: A laser is used to vaporize the abnormal cells. This is highly effective for multifocal disease (patches in multiple spots) ^[1]. Studies show that once invasive cancer is ruled out, laser treatment and surgical excision have similar success rates ^[1]^[5].
Topical Imiquimod: This is an immune-response modifier cream. In the vagina, this is an off-label, specialist-directed option rather than a routine alternative. It is often used for persistent patches, or for patients who cannot undergo surgery ^[1]. While it can be very effective in selected cohorts, it requires strict clinician monitoring and can cause local irritation, erosions, or flu-like symptoms ^[6]^[7]^[8].

Inflammatory Conditions (Lichen Planus)

As discussed on the previous page, these are managed with medications like clinician-directed topical steroids rather than surgery ^[9]. The focus is on reducing inflammation and preventing the vagina from narrowing or scarring ^[10].

Finding the Right Specialist

Vaginal lesions are less common than cervical ones, and their management can be complex. It is often beneficial to seek care from a gynecologic oncologist or a gynecologist who specializes in “lower genital tract disorders” for confirmed high-grade disease or concerns about invasion. These specialists have advanced training in the use of specialized tools like the CO2 laser and the surgical techniques needed to navigate the thin walls of the vagina ^[1].

Red Flags: Post-Procedure Emergencies vs. Prompt Check-Ups

While many symptoms (like mild discharge or spotting after a biopsy) are normal, it is important to distinguish between symptoms that require immediate emergency care and those that mean you should contact your clinic promptly ^[11].

Seek immediate emergency care if you experience:

Heavy, Bright Red Bleeding: Especially after a biopsy or surgery, if you are soaking through a pad in an hour ^[11].
Inability to Urinate: Or severe burning that prevents urination after a procedure.
Signs of Treatment Complications: After a procedure, seek help for a high fever, feeling faint/dizzy, or intense, worsening pain ^[12]^[13].

Contact your care team promptly for:

Postmenopausal Bleeding: Unexplained bleeding after menopause requires evaluation ^[14].
Foul-Smelling or Watery Discharge: This can sometimes be a sign of infection or a changing lesion ^[14].
A Rapidly Growing or Ulcerated Lump: If a previously flat white patch becomes a raised, firm, or open sore (ulcer) ^[15].

The Importance of Long-Term Follow-Up

Regardless of which treatment you receive, the most critical “next step” is showing up for your follow-up appointments. High-grade VaIN has a tendency to recur, sometimes years after treatment ^[16]^[17]. The exact schedule depends on your diagnosis. For treated high-grade VaIN, most consensus guidelines recommend a check-up every 6 months for the first two years, involving a visual exam, a swab for abnormal cells (cytology), and an HPV test ^[1]. After two years of clear results, you may move to annual exams ^[1].

Common questions in this guide

What happens if my biopsy shows low-grade VaIN?

Low-grade VaIN, also called VaIN 1 or vLSIL, often does not need immediate treatment because it may resolve as the immune system clears the viral changes. Doctors commonly recommend close monitoring with a repeat examination and HPV test in about 6 to 12 months.

How are high-grade vaginal cell changes treated?

High-grade VaIN, including VaIN 2 or 3, generally needs active treatment because it has a greater risk of progressing to cancer. Surgical excision may be preferred when invasion cannot be ruled out, while CO2 laser ablation may be useful for lesions in several areas after invasive cancer has been excluded.

Is imiquimod an option for vaginal leukoplakia?

Imiquimod is an off-label, specialist-directed option for selected patients, such as those with persistent lesions or those who cannot have surgery. It can cause irritation, erosions, discharge, or flu-like symptoms, so treatment requires careful monitoring by a clinician.

How is vaginal leukoplakia related to lichen planus treated?

When the biopsy shows an inflammatory condition such as lichen planus, treatment usually focuses on clinician-directed topical steroids rather than removing tissue. The goals are to reduce inflammation and help prevent scarring or narrowing of the vagina.

When should I seek urgent help after a vaginal biopsy or procedure?

Seek emergency care for heavy bright-red bleeding that soaks a pad in an hour, inability to urinate, a high fever, faintness or dizziness, or intense and worsening pain. Contact your care team promptly for postmenopausal bleeding, foul-smelling or watery discharge, or a rapidly growing or ulcerated lesion.

How often will I need follow-up after treatment for high-grade VaIN?

Follow-up is individualized, but consensus guidance commonly recommends an examination, cytology, and HPV test every 6 months for the first 2 years after treatment for high-grade VaIN. If results remain clear after 2 years, follow-up may change to annual examinations, because recurrence can occur later.

Get notified when new evidence is published on leukoplakia of vagina.

We monitor PubMed for new peer-reviewed studies on this topic and email a short summary when something meaningful changes.

References (17)

1
The European Society of Gynaecological Oncology (ESGO), the International Society for the Study of Vulvovaginal Disease (ISSVD), the European College for the Study of Vulval Disease (ECSVD), and the European Federation for Colposcopy (EFC) consensus statement on the management of vaginal intraepithelial neoplasia.
Kesic V, Carcopino X, Preti M, et al.
International journal of gynecological cancer : official journal of the International Gynecological Cancer Society 2023; (33(4)):446-461 doi:10.1136/ijgc-2022-004213.
PMID: 36958755
2
A retrospective study of 152 women with vaginal intraepithelial neoplasia.
Zhang J, Chang X, Qi Y, et al.
International journal of gynaecology and obstetrics: the official organ of the International Federation of Gynaecology and Obstetrics 2016; (133(1)):80-3.
PMID: 26797205
3
Clinical outcomes and risk of recurrence among patients with vaginal intraepithelial neoplasia: a comprehensive analysis of 576 cases.
Kim MK, Lee IH, Lee KH
Journal of gynecologic oncology 2018; (29(1)):e6 doi:10.3802/jgo.2018.29.e6.
PMID: 29185264
4
Vaginal Intraepithelial Neoplasia: Histopathological Upgrading of Lesions and Evidence of Occult Vaginal Cancer.
Sopracordevole F, De Piero G, Clemente N, et al.
Journal of lower genital tract disease 2016; (20(1)):70-4 doi:10.1097/LGT.0000000000000150.
PMID: 26461231
5
Management options for vaginal intraepithelial neoplasia.
Rountis A, Pergialiotis V, Tsetsa P, et al.
International journal of clinical practice 2020; (74(11)):e13598 doi:10.1111/ijcp.13598.
PMID: 32602195
6
Randomised trial on treatment of vaginal high-grade squamous intraepithelial lesion: Self-administered vaginal imiquimod and laser vaporisation.
Kiviharju M, Riska A, Kalliala I, et al.
International journal of cancer 2025; (157(7)):1458-1464 doi:10.1002/ijc.35497.
PMID: 40454918
7
Efficacy of 5% imiquimod for the treatment of Vaginal intraepithelial neoplasia-A systematic review of the literature and a meta-analysis.
Tranoulis A, Laios A, Mitsopoulos V, et al.
European journal of obstetrics, gynecology, and reproductive biology 2017; (218()):129-136 doi:10.1016/j.ejogrb.2017.09.020.
PMID: 28985547
8
Imiquimod for Cervical and Vaginal Intraepithelial Neoplasia: A Systematic Review and Meta-analysis.
Inayama Y, Takamatsu S, Hamanishi J, et al.
Obstetrics and gynecology 2023; (142(2)):307-318 doi:10.1097/AOG.0000000000005256.
PMID: 37411024
9
Diagnosis and Management of Vulvovaginal Lichen Planus.
Jacques L, Kornik R, Bennett DD, Eschenbach DA
Obstetrical & gynecological survey 2020; (75(10)):624-635 doi:10.1097/OGX.0000000000000834.
PMID: 33111963
10
Outcomes After Lysis of Adhesions and Dilator Placement for Treatment of Vulvovaginal Agglutination Due to Lichen Planus.
Russell CB, Welch KC, Saunders NA, et al.
Journal of lower genital tract disease 2023; (27(2)):152-155 doi:10.1097/LGT.0000000000000724.
PMID: 36688796
11
Management of Vaginal Cancer.
Shrivastava SB, Agrawal G, Mittal M, Mishra P
Reviews on recent clinical trials 2015; (10(4)):289-97 doi:10.2174/1574887110666150923112958.
PMID: 26411952
12
Laser Excisional Treatment for Vaginal Intraepithelial Neoplasia to Exclude Invasion: What Is the Risk of Complications?
Sopracordevole F, Moriconi L, Di Giuseppe J, et al.
Journal of lower genital tract disease 2017; (21(4)):311-314 doi:10.1097/LGT.0000000000000326.
PMID: 28953124
13
Strangulated bowel obstruction caused by vaginal perforation due to vaginal cancer in a patient with chronic uterine prolapse.
Fukai S, Maeda S, Chikazawa K, Rikiyama T
BMJ case reports 2023; (16(12)) doi:10.1136/bcr-2023-255815.
PMID: 38086574
14
Multimodal ultrasound imaging in the diagnosis of primary vaginal malignant melanoma: A case report.
Qin HC, Wang MY, Ye DQ, Zhu J
Medicine 2026; (105(27)):e49636 doi:10.1097/MD.0000000000049636.
PMID: 42410847
15
Vaginal Carcinoma with Third-Degree Uterine Prolapse.
Sheikh NK, Date SS, Darekar YS
International journal of applied & basic medical research 2019; (9(4)):246-247 doi:10.4103/ijabmr.IJABMR_211_18.
PMID: 31681552
16
High-Grade Vaginal Intraepithelial Neoplasia: Clinical Profile, HPV Vaccination Status, and Treatment Outcomes at Two Italian Referral Centers.
Gallio N, Preti M, Boldorini R, et al.
Vaccines 2025; (13(11)) doi:10.3390/vaccines13111089.
PMID: 41295462
17
High-grade vaginal intraepithelial neoplasia and recurrence risk: analysis of an Italian regional referral center series.
Monti E, Libutti G, Di Loreto E, et al.
Archives of gynecology and obstetrics 2023; (308(1)):201-206 doi:10.1007/s00404-022-06886-6.
PMID: 36564638

This page explains treatment and follow-up for vaginal leukoplakia and related biopsy findings for informational purposes only and does not constitute medical advice. Your gynecologist or gynecologic oncologist should interpret your results and recommend care for your situation.

Guide Contents